Population-Based Survey of Filamentous Fungi and Antifungal Resistance in Spain (FILPOP Study)

Author:

Alastruey-Izquierdo A.,Mellado E.,Peláez T.,Pemán J.,Zapico S.,Alvarez M.,Rodríguez-Tudela J. L.,Cuenca-Estrella M.,

Abstract

ABSTRACTA population-based survey was conducted to investigate the epidemiology of and antifungal resistance in Spanish clinical strains of filamentous fungi isolated from deep tissue samples, blood cultures, and respiratory samples. The study was conducted in two different periods (October 2010 and May 2011) to analyze seasonal variations. A total of 325 strains were isolated in 29 different hospitals. The average prevalence was 0.0016/1,000 inhabitants. Strains were identified by sequencing of DNA targets and susceptibility testing by the European Committee for Antimicrobial Susceptibility Testing reference procedure. The most frequently isolated genus wasAspergillus, accounting for 86.3% of the isolates, followed byScedosporiumat 4.7%; the order Mucorales at 2.5%;Penicilliumat 2.2%, andFusariumat 1.2%. The most frequent species wasAspergillus fumigatus(48.5%), followed byA. flavus(8.4%),A. terreus(8.1%),A. tubingensis(6.8%), andA. niger(6.5%). Cryptic/siblingAspergillusspecies accounted for 12% of the cases. Resistance to amphotericin B was found in 10.8% of the isolates tested, while extended-spectrum triazole resistance ranged from 10 to 12.7%, depending on the azole tested. Antifungal resistance was more common among emerging species such as those ofScedosporiumand Mucorales and also among cryptic species ofAspergillus, with 40% of these isolates showing resistance to all of the antifungal compounds tested. CrypticAspergillusspecies seem to be underestimated, and their correct classification could be clinically relevant. The performance of antifungal susceptibility testing of the strains implicated in deep infections and multicentric studies is recommended to evaluate the incidence of these cryptic species in other geographic areas.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3